A nuclear factor-kappaB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells

Jpn J Pharmacol. 2002 May;89(1):81-4. doi: 10.1254/jjp.89.81.

Abstract

BAY 11-7082, an inhibitor of nuclear factor-kappaB (NF-kappaB), which prevents a step of the phosphorylation of inhibitory protein IkappaB bound to NF-kappaB, suppressed basal and tumor necrosis factor (TNF)-alpha-induced prepro endothelin (ET)-1 mRNA expression and NF-kappaB activation in cultured vascular endothelial cells. BAY 11-7082 significantly decreased basal and TNF-alpha-induced ET-1 release from endothelial cells. These results indicate that the inhibition of NF-kappaB activation contributes to the suppressive effect of BAY 11-7082 on ET-1 gene expression and ET-1 release, thereby suggesting that NF-kappaB plays an important role in the regulation of ET-1 production.

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Aorta
  • Blotting, Western
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Endothelin-1 / biosynthesis*
  • Endothelin-1 / genetics
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • NF-kappa B / antagonists & inhibitors*
  • Nitriles*
  • Organic Chemicals*
  • RNA, Messenger / biosynthesis
  • Sulfones*
  • Swine

Substances

  • 3-(4-methylphenylsulfonyl)-2-propenenitrile
  • Antineoplastic Agents
  • Endothelin-1
  • NF-kappa B
  • Nitriles
  • Organic Chemicals
  • RNA, Messenger
  • Sulfones